Thursday, October 03, 2019 7:30:28 PM
It may be a pipe dream but I refuse to believe that a delay in timeline dismisses everything Algernon has set up for getting their compounds noticed by pharma or possible partnerships. There is no way they will have enough funding to get these trials done if outside investors become impatient and start pulling out their money. There must be another source being looked into. Either that or this will not make it to Phase IIb but I doubt that with the results we have seen from the repurposed compounds. Who knows? AMG has been the guy who has done more DD here than anyone and he seems fed up. So I really don't know what to think at this point. I really thought Algernon was the one to break free from the Bullrun trend and would hit the homerun. Maybe that is still the case but let's see how the stock price plays out and what's to come. Management has been forthcoming up until this point which is more than I can say for BLOZF
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM